Careprost vs. Latisse: Which Eyelash Serum Really Works Better?

Latisse and Careprost are two popular products for improving eyelash growth. While they serve a similar purpose and contain the same active ingredient, some differences exist in their origins and regulatory status.

This guide provides an in-depth comparison of Latisse vs. Careprost explaining; Latisse or Careprost, Careprost vs Latisse, difference between Careprost and Latisse, what is difference of Careprost and Latisse, Careprost same as Latisse, Careprost compared to Latisse, does Careprost work as well as Latisse, is Latisse better than Careprost and more to help you make informed decisions.

What is Latisse?

Latisse contains bimatoprost (a prostaglandin analog), it is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) in 2008 for the treatment of hypotrichosis. Hypotrichosis is a condition in which there are inadequate or insufficient eyelashes. Latisse is the first and only FDA-approved treatment for eyelash growth, making it a trusted and regulated option in the market.

What is Careprost?

Careprost is a generic version of Latisse. Careprost contains the same active ingredient as Latisse, bimatoprost. It is marketed as an ophthalmic solution for the treatment of glaucoma and ocular hypertension (increased pressure in the eye). Careprost is not specifically approved for eyelash enhancement, but it is commonly used off-label for this purpose because it has the same composition and efficacy.

Active Ingredient of Careprost vs. Latisse

There is no difference between Careprost and Latisse regarding the active ingredient. Both Latisse and Careprost contain bimatoprost, a prostaglandin analog. Bimatoprost works by extending the growth phase (anagen phase) of the eyelash hair cycle. Thus, it increases the number of hairs in this phase. This results in longer, thicker, and darker eyelashes over time.

The way bimatoprost was found to be effective in eyelash growth is interesting. Initially, it was used to treat glaucoma. However, patients using bimatoprost for glaucoma reported significant eyelash growth as a side effect. This led to the development and marketing of Latisse specifically for cosmetic purposes.

Usage of Latisse vs. Careprost

There is no difference between Careprost and Latisse in terms of usage. Both have the same active ingredients, so both can be used to enhance eyelash growth for the treatment of hypotrichosis.

How to Use Careprost vs. Latisse?

Latisse is packaged with sterile, single-use applicators to provide precise and hygienic application. Patients are advised to apply Latisse to the base of the upper eyelashes once a day, usually in the evening. It is important to follow the instructions carefully to avoid contamination for effective results. Noticeable improvements in eyelash length and thickness are seen after 8 weeks of consistent use, with full results visible after 16 weeks.

Careprost is usually sold as a solution without specific applicators. Users often need to purchase separate applicators or use clean eyeliner brushes for application.  The method of application od Careprost is same as Latisse. The solution is applied to the base of the upper eyelashes once daily. Like Latisse, Careprost users can expect to see results within 8 to 16 weeks.

Efficacy of Latisse vs. Careprost

Since both contain the active ingredient bimatoprost, you may think is Latisse better than Careprost or does Careprost work as well as Latisse? There is not much difference in the efficacy of Careprost compared to Latisse. Clinical studies and user testimonials support the effectiveness of both Careprost and Latisse in enhancing eyelash length, thickness, and darkness. Consistent use of either product as directed can lead to significant improvements in the appearance of eyelashes.

Safety and Side Effects of Careprost Compared to Latisse

As an FDA-approved product, Latisse has undergone testing to ensure its safety and efficacy. Common side effects include eye redness, itching, dryness, and darkening of the eyelid skin. In rare cases, Latisse can cause increased brown pigmentation of the iris, which may be permanent. Users are advised to avoid applying the solution to the lower lashes or getting it into the eyes to minimize potential side effects.

While Careprost contains the same active ingredient as Latisse, its use for eyelash growth is considered off-label, meaning regulatory authorities have not specifically approved it for this purpose. The side effects of Careprost are similar to those of Latisse, including eye redness, itching, and skin darkening. However, because it is not FDA-approved for cosmetic use, there may be less oversight regarding its safety and potential side effects when used for eyelash growth.

Cost and Availability of Careprost Compared to Latisse

Latisse is a branded product and thus is more expensive than generic alternatives. It is available by prescription only. However, purchasing Latisse through legitimate channels ensures that users receive a product that meets FDA standards for safety and efficacy.

Careprost is generally more affordable than Latisse. It can be purchased online from various retailers, often without a prescription. This ease of access makes Careprost a preferred option over Latisse for many.

Conclusion: Latisse vs. Careprost

In conclusion, Latisse and Careprost are both effective options for enhancing eyelash growth. Latisse’s FDA approval and strict regulatory requirements make it a trusted and reliable choice, although at a higher price. Careprost offers a more affordable alternative, but with less regulatory assurance when used off-label for eyelash growth.

It is recommended to weigh the benefits and risks of each product, considering factors such as cost, safety, and regulatory status. Whether opting for Latisse or Careprost, you can achieve longer, thicker, and darker eyelashes with consistent use and proper application.

Frequently Asked Questions (FAQs) about Careprost vs Latisse

1. What is the difference of Careprost and Latisse?

Both Careprost and Latisse have the same active ingredient bimatoprost and both are used to enhance eyelash thickness and length. The difference between them is that Latisse is the FDA-approved brand and Careprost is a generic alternative.

2. Is Careprost the same as Latisse?

Yes! Careprost has the same active ingredient as Latisse and has the same use and dosage. Latisse is the well-known brand name of bimatoprost while Careprost is the generic version.

3. Does Careprost work as well as Latisse?

The efficacy comparison of Careprost vs. Latisse indicates that Careprost works almost as well as Latisse but not better than Latisse.

4. Which is better: Latisse or Careprost?

Latisse is an FDA-approved brand and may show slightly better results than Careprost. But it is more expensive than Careprost. So, deciding Latisse or Careprost, depends on personal preference.

5. How does the side effects of Careprost compare to Latisse?

The safety profile of Careprost is similar to Latisse. Both have the same effects like eye redness, itching, dryness, and darkening of the eyelid skin.

References:

1. Johnstone, M. A., & Albert, D. M. (2002). Prostaglandin-induced hair growth. Survey of Ophthalmology, 47(S1), S185-S202. https://doi.org/10.1016/S0039-6257(02)00305-1
2. Smith, S., & Fagien, S. (2010). Eyelash growth in subjects treated with bimatoprost: Results from a randomized, double-masked, vehicle-controlled, parallel-group study. Journal of the American Academy of Dermatology, 62(6), 1040-1050. https://doi.org/10.1016/j.jaad.2009.08.050
3. Dixon, S. (2011). The science behind Latisse (bimatoprost 0.03%): An overview. Clinical, Cosmetic and Investigational Dermatology, 4, 281-285. https://doi.org/10.2147/CCID.S14480
4. Doshi, A. R., & Aggarwal, R. (2014). Off-label use of bimatoprost in dermatology. Journal of Dermatological Treatment, 25(4), 303-307. https://doi.org/10.3109/09546634.2013.790591
5. Gupta, A. K., & Charrette, A. (2019). The efficacy and safety of bimatoprost 0.03% solution in treating eyelash hypotrichosis: A meta-analysis. Dermatologic Therapy, 32(5), e13043. https://doi.org/10.1111/dth.13043
6. Gupta, A. K., & Charrette, A. (2019). The efficacy and safety of bimatoprost 0.03% solution in treating eyelash hypotrichosis: A meta-analysis. Dermatologic Therapy, 32(5), e13043. https://doi.org/10.1111/dth.13043

Post by:

 Dr.Marcella Jiovanni

Health and Beauty Expert

“Marcella Jiovanni actively promotes the importance of maintaining healthy skin, she envisions the future of dermatology as moving away from pure medical, pharmacological dermatology and flowing more toward a holistic approach to wellness and skincare.”